Intravitreal bevacizumab for retinopathy of prematurity in infants ineligible for laser therapy


HONDUR A. M. , Cubuk M. O. , Ozen Tunay Z., ATALAY H. T. , Ozdemir O., Petricli I. S. , ...Daha Fazla

TURKISH JOURNAL OF MEDICAL SCIENCES, cilt.46, sa.3, ss.764-768, 2016 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 46 Konu: 3
  • Basım Tarihi: 2016
  • Doi Numarası: 10.3906/sag-1502-65
  • Dergi Adı: TURKISH JOURNAL OF MEDICAL SCIENCES
  • Sayfa Sayıları: ss.764-768

Özet

Background/ aim: To evaluate refractive and strabismic results and the efficacy of intravitreal bevacizumab in retinopathy of prematurity (ROP) ineligible for laser therapy.